Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Ifrah

Showing results (81-90 of 169) with videos related to

Pageof 17
Sort By:
Leukemia|November 27, 2019
Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantationAnne Bouvier, Jérémie Riou, Sylvain Thépot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2017
Early Response-Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia StudyJonathan Bond, Carlos Graux, Ludovic Lhermitte, et al.
Blood|April 23, 2020
Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 studyCorentin Orvain, Marie Balsat, Emmanuelle Tavernier, et al.
Haematologica|September 22, 2011
High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) studyFrançois Vergez, Alexa S Green, Jerome Tamburini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2019
Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALLAurore Touzart, Etienne Lengliné, Mehdi Latiri, et al.
Blood|July 30, 2010
The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translationAlexa S Green, Nicolas Chapuis, Thiago Trovati Maciel, et al.
Haematologica|January 19, 2019
<i>DNMT3A</i> mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemiaJonathan Bond, Aurore Touzart, Stéphane Leprêtre, et al.
Molecular Cancer|January 17, 2023
Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALLCharlotte Smith, Aurore Touzart, Mathieu Simonin, et al.
Blood|December 26, 2008
NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) studyVahid Asnafi, Agnès Buzyn, Sandrine Le Noir, et al.
Oncoimmunology|December 7, 2017
NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AMLAnne-Sophie Chretien, Raynier Devillier, Cyril Fauriat, et al.
Pageof 17

Showing results (81-90 of 169) with videos related to

Sort By:
Pageof 17
Leukemia|November 27, 2019
Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantationAnne Bouvier, Jérémie Riou, Sylvain Thépot, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2017
Early Response-Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia StudyJonathan Bond, Carlos Graux, Ludovic Lhermitte, et al.
Blood|April 23, 2020
Thromboembolism prophylaxis in adult patients with acute lymphoblastic leukemia treated in the GRAALL-2005 studyCorentin Orvain, Marie Balsat, Emmanuelle Tavernier, et al.
Haematologica|September 22, 2011
High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) studyFrançois Vergez, Alexa S Green, Jerome Tamburini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2019
Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALLAurore Touzart, Etienne Lengliné, Mehdi Latiri, et al.
Blood|July 30, 2010
The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translationAlexa S Green, Nicolas Chapuis, Thiago Trovati Maciel, et al.
Haematologica|January 19, 2019
<i>DNMT3A</i> mutation is associated with increased age and adverse outcome in adult T-cell acute lymphoblastic leukemiaJonathan Bond, Aurore Touzart, Stéphane Leprêtre, et al.
Molecular Cancer|January 17, 2023
Harnessing the MYB-dependent TAL1 5'super-enhancer for targeted therapy in T-ALLCharlotte Smith, Aurore Touzart, Mathieu Simonin, et al.
Blood|December 26, 2008
NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) studyVahid Asnafi, Agnès Buzyn, Sandrine Le Noir, et al.
Oncoimmunology|December 7, 2017
NKp46 expression on NK cells as a prognostic and predictive biomarker for response to allo-SCT in patients with AMLAnne-Sophie Chretien, Raynier Devillier, Cyril Fauriat, et al.
Pageof 17